Supraventricular tachycardia. II.
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use; D000787:Angina Pectoris / Q000150:complications; D001146:Arrhythmia, Sinus / Q000139:chemically induced; D002037:Bundle-Branch Block / Q000175:diagnosis; D003937:Diagnosis, Differential; D004077:Digoxin / Q000009:adverse effects / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009230:Myxedema / Q000188:drug therapy; D013610:Tachycardia / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013974:Thyroxine / Q000009:adverse effects
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D004077:Digoxin; D008012:Lidocaine; D013974:Thyroxine